Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease.
dc.contributor.author | Shaw, Bronwen E | |
dc.contributor.author | Apperley, Jane F | |
dc.contributor.author | Russell, Nigel | |
dc.contributor.author | Craddock, Charles | |
dc.contributor.author | Liakopoulou, Effie F | |
dc.contributor.author | Potter, Mike N | |
dc.contributor.author | Wynn, Robert F | |
dc.contributor.author | Gibson, Brenda E | |
dc.contributor.author | Pearce, Rachel M | |
dc.contributor.author | Kirkland, Keiren E | |
dc.contributor.author | Lee, Julia | |
dc.contributor.author | Madrigal, J Alejandro | |
dc.contributor.author | Cook, Gordon | |
dc.contributor.author | Byrne, Jennifer L | |
dc.date.accessioned | 2011-07-21T12:19:30Z | |
dc.date.available | 2011-07-21T12:19:30Z | |
dc.date.issued | 2011 | |
dc.identifier.citation | Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease. 2011, 153 (2):244 Br J Haematol | en |
dc.identifier.issn | 00071048 | |
dc.identifier.pmid | 21382020 | |
dc.identifier.doi | 10.1111/j.1365-2141.2011.08615.x | |
dc.identifier.uri | http://hdl.handle.net/10541/136516 | |
dc.language.iso | en | en |
dc.title | Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease. | en |
dc.type | Article | en |
dc.contributor.department | Anthony Nolan Trust, London | en |
dc.identifier.journal | British Journal of Haematology | en |